小剂量尿激酶与降纤酶治疗进展型脑梗死的对比性研究  

A COMPARATIVE STUDY BETWEEN LOW DOSE OF UROKINASE AND DEFIBRASE IN THE TREATMENT OF PROGRESSIVE CEREBRAL IN FARCTION

作　　者：袁亮方[1] 姜国晶[1] 张超[1] 张红[1] 张岩[1] 

机构地区：[1]天津市第三医院神经内科,天津300250

出　　处：《牡丹江医学院学报》2009年第4期27-29,共3页Journal of Mudanjiang Medical University

摘　　要：目的:探讨能够阻止进展型脑梗死进展的有效治疗方法。方法:对符合入选标准的病人,根据我们在临床上常用的小剂量尿激酶(UK)和降纤酶随机分成两组,在治疗前后对疗效、并发症、有无恶化等情况进行比较分析。结果:小剂量尿激酶组较降纤酶组有更好的疗效。结论:小剂量尿激酶对进展型脑梗死病人有较好的临床疗效和安全性。Objective：To explore an effective treatment method that can stop the development of progressive cerebral. Methods：Patients who meets the inclusion criteria were randomly divided into two groups, on the basis of our commonly used in clinical low - dose urokinase （UK） and defibrase. The efficacy, complications, the situation were deteriorated whether or not was compared before and after treatment. Results： Low - dose urokinase group has a better effect than defibrase group. Conclusion ： Low - dose urokinase treatment has better clinical efficacy and safety on the progressive cerebral infarction patients.

关 键 词：进展型脑梗死 尿激酶 降纤酶 治疗结果 

分 类 号：R741[医药卫生—神经病学与精神病学]